Susquehanna Fundamental Investments’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-26,600
Closed -$3.63M 1677
2020
Q3
$3.63M Buy
26,600
+6,100
+30% +$649K 0.11% 252
2020
Q2
$1.98M Buy
+20,500
New +$1.71M 0.09% 278

Susquehanna Fundamental Investments's MYOK Position: Q4 2020 in Review

Susquehanna Fundamental Investments sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 26,600 shares — an estimated $3.63M sold.

Susquehanna Fundamental Investments first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $3.63M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Susquehanna Fundamental Investments reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 26,600 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $3.63M.
  • Susquehanna Fundamental Investments first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Susquehanna Fundamental Investments's MyoKardia, Inc. Common Stock position peaked at $3.63M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2020, filed 16 Feb 2021.